Modifications in the bradykinin main chain are not necessary for antagonistic activity in rat blood pressure assay

Journal of Peptide Science

Volumn 13, Issue 3, 2007, Pages 206-210

  Prahl, Adam ^a  

^a UNIVERSITY OF GDA SK   (Poland)

Author keywords

B2 antagonists; Bradykinin; Rat blood pressure assay; Rat uterotonic test in vitro

Indexed keywords

ACRIDIN 9 YLACETIC ACID BRADYKININ; ANTHRACEN 9 YLACETIC ACID BRADYKININ; BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ B2 RECEPTOR; BRADYKININ DERIVATIVE; ENALAPRIL; UNCLASSIFIED DRUG;

ACYLATION; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONCENTRATION RESPONSE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DESIGN; DRUG DOSE INCREASE; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RAT; SOLID PHASE SYNTHESIS; UTERUS CONTRACTION;

ACRIDINES; ACYLATION; ANIMALS; ANTHRACENES; BLOOD PRESSURE; BRADYKININ; FEMALE; MALE; RATS; RATS, WISTAR; RECEPTOR, BRADYKININ B2; UTERINE CONTRACTION;

RATTUS;

EID: 33947242753     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.830     Document Type: Article

References (17)

1. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens, and related kininases. Pharmacol. Rev. 1992; 44: 1-78.
2. Vavrek RJ, Stewart JM. Competitive Antagonists of bradykinin. Peptides 1985; 6: 161-164.
3. 2 bradykinin antagonist. In Bradykinin Antagonists. Basic and Clinical Research, Burch RM (ed.). Marcel Dekker Inc: New York-Basel, 1991; 51-96.
4. Mulinari R, Benetos A, Gavras I, Gavras H. Vascular and sympathoadrenal responses to bradykinin and a bradykinin analogue. Hypertension 1988; 11: 754-757.
5. Hock FJ, Wirth K, Albas U, Linz W, Gerhards HJ, Wiemer G, Henke S, Breipohl G, Konig W, Knolle J, Seholkens BA. A new potent and long acting bradykinin antagonists. Br. J. Pharmacol. 1991; 102: 769-773.
6. Stewart J, Gera L, Hanson W, Juzack J, Burkard M, Mc Cullough R, Whalley ET. A new generation bradykinin antagonists. Immunopharmacology 1996; 33: 51-60.
7. 2-antagonists of bradykinin. Pol. J. Chem. 1994; 68: 913-920.
8. Prahl A, Wierzba T, Wszedybył M, Juzwa W, Lammek B. Design and synthesis of new bradykinin antagonists with N-terminal acylation. Pol. J. Chem. 1997; 71: 915-922.
9. Trzeciak HI, Kozik W, Melhem S, Kania A, Dobrowolski D, Prahl A, Derdowska I, Lammek B. New bradykinin analogs in contraction of rat utems. Peptides 2000; 21: 829-834.
10. Wang S. p-Alkoxybenzyl alcohol resin and p-alkoxybenzyloxy-carbonylhydrazide resin for solid phase synthesis of protected peptide fragments. J. Am. Chem. Soc. 1973; 95: 1328-1333.
11. Holton PA. Modification of the method of Dale and Laidlaw for standardization of posterior pituitary extract. Br. J. Pharmacol. 1948; 3: 328-334.
12. Munsick R. Effect of magnesium ion on the response of the rat uterus to neurohypophysial hormones and analogues. Endocrinology 1960; 66: 451-457.
13. Vavrek RJ, Gera L, Stewart JM. Bradykinin antagonists do not require a D-aromatic amino acid residue at position 7. Agents Actions Suppl. 1992; 38(Pt 1): 572-581.
14. Reissmann S, Schwuchow C, Seyfarth L, Pineda de Castro LF, Liebmann C, Paegelow I, Werner H, Stewart JM. Highly selective bradykinin agonists and antagonists with replacement of praline residues ny N-methyl-D- and L-phenylalanine. J. Med. Chem. 1996; 39: 929-936.
15. Derdowska I, Prahl A, Neubert K, Hartrodt B, Trzeciak H, Klimanek M, Winklewski P, Wierzba T, Juzwa W, Lammek B. New bradykinin antagonists containing a conformationally restricted dipeptide fragment in their molecules. J. Pept. Res. 2001; 57: 11-18.
16. Prahl A, Wierzba T, Winklewski P, Wszȩdybył M, Cherek M, Juzwa W, Lammek B. Influence of C-terminal modifications of bradykinin antagonists on their activity. Collect. Czech. Chem. Commun. 1997; 62: 1940-1946.
17. Labudda-Dawidowska O, Wierzba TH, Prahl A, Kowalczyk W, Gawifiski L, Plackova M, Slaninová J, Lammek B. New bradykinin analogues modified in C-terminal part with sterically restricted 1-aminocyclohexane-1-carboxylic acid. J. Med. Chem. 2005; 48(25): 8055-8059.